| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710334 | Null | 0.0244632509325736 | 0.39762595 |
| NSC 722222 | Null | 0.0244632509325736 | 0.063984534 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0244632509325736 | 0.2764758 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0244632509325736 | -0.10368726 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0244632509325736 | 0.38196293 |
| NSC 756166 | GSK312948A | 0.0244632509325736 | 0.36992183 |
| NSC 756304 | GW678313X | 0.0244632509325736 | -0.23849029 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0244632509325736 | 0.36486517 |
| NSC 94600 | Camptothecin | 0.0244632509325736 | -0.025532732 |
| NSC 180260 | Quinolinium, 1-methyl-4-[2-(2,4,5-trimethoxyphenyl)ethenyl]-, iodide | 0.0244718705444135 | 0.10136782 |